Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages
DOCUMENT DATABASE

22nd Century Group

xxiicentury.com

chapterxv1030005.1
Chardan-Analyst-Report-March-9-2017
PM Alkaloid Reduced Tobacco Program
WSJ – Jan 16, 2001
Xxii 2014-01-10 $1.80 Initiate Coverage with Buy and $9 Target
Xxii 2014-01-31 $2.63 Q4 Operating Income and CF Exceed Estimates. Maintain Buy and $9 Target
Xxii 2014-02-10 $2.70 Update from Management Meetings
Xxii 2014-03-17 $4.60 Company Update. Attractive Entry Point
Xxii 2014-04-02 ~$3.31 Weakness on Warrant Amendment
Xxii 2014-04-10 ~$2.83 FDA Reference Cigarette Award to U of Kentucky
Xxii 2014-04-21 ~$2.76 XXII files mixed-use shelf, and provides update
Xxii 2014-06-09 $3.14 Company Update
Xxii 2014-07-15 $2.92 Modified Risk Trial Expected Q4
Xxii 2014-09-23 $2.68 Recent Deals Significantly Strengthen Company. Remains Our Top Pick
Xxii 2014-10-01 $2.52 China JV, Another Billion Dollar Opportunity
Xxii 2014-11-26 $1.95 Company Provides Bullish Business Update. Reiterate Buy.
Xxii 2015-01-20 $1.40 Plant Tour This Week
Xxii 2015-01-26 $1.23 Bullish View of Recent Plant Tour
XXII Meeting Takeaways – Implications for Big Tobacco
XXII_2014-11-17
XXII_2015-02-12
XXII_2015-04-28
XXII_2015-05-12
XXII_2015-07-10
XXII_2015-08-06
XXII_2015-09-28
XXII_2015-11-11
XXII_2015-12-03
XXII_2016-01-20
XXII_2016-02-16
XXII_2016-02-22
XXII_2016-04-18
XXII_2016-05-02
XXII_2016-05-16
XXII_2016-07-26
XXII_2016-08-10
XXII_2016-08-11
XXII_2016-09-28
XXII_2016-10-17
XXII_2016-11-09
XXII_2017-01-05
XXII_2017-03-07
XXII_2017-05-01
XXII_2017-05-10
XXII_2017-06-22
XXII_2017-07-28
XXII_2017-07-30
XXII_2017-08-10
XXII_2017-10-16
XXII_2017-11-08
XXII_2018-01-24
XXII_2018-01-26
XXII_2018-02-28
XXII_2018-03-08
XXII_2018-03-12
XXII_2018-03-15
XXII_2018-03-19
XXII_Initiation-5-16-11-restricted

error: Content is protected